loadpatents
name:-0.013721942901611
name:-0.0032241344451904
name:-0.00034904479980469
Gaud; Henry T. Patent Filings

Gaud; Henry T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gaud; Henry T..The latest application filed is for "eplerenone drug substance having high phase purity".

Company Profile
0.3.11
  • Gaud; Henry T. - Evanston IL
  • Gaud; Henry T - Evanston IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Synthesis of diaryl pyrazoles
Grant 7,759,497 - Letendre , et al. July 20, 2
2010-07-20
Eplerenone Drug Substance Having High Phase Purity
App 20090149431 - Barton; Kathleen P. ;   et al.
2009-06-11
Crystalline Form Of 4-[5-methyl-3-phenylisoxazol-4-yl] Benzenesulfonamide
App 20070072921 - Talley; John J. ;   et al.
2007-03-29
Synthesis of diaryl pyrazoles
Grant 7,141,678 - Letendre , et al. November 28, 2
2006-11-28
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide
Grant 7,135,489 - Talley , et al. November 14, 2
2006-11-14
Eplerenone crystalline form exhibiting enhanced dissolution rate
App 20050267302 - Barton, Kathleen P. ;   et al.
2005-12-01
Eplerenone drug substance having high phase purity
App 20050261261 - Barton, Kathleen P. ;   et al.
2005-11-24
Eplerenone crystal form exhibiting enhanced dissolution rate
App 20050159594 - Barton, Kathleen P. ;   et al.
2005-07-21
Synthesis of diaryl pyrazoles
App 20040024225 - Letendre, Leo J. ;   et al.
2004-02-05
Eplerenone drug substance having high phase purity
App 20030083493 - Barton, Kathleen P. ;   et al.
2003-05-01
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-YL] benzenesulfonamide
App 20030004200 - Talley, John J. ;   et al.
2003-01-02
Eplerenone crystalline form
App 20020045746 - Barton, Kathleen P. ;   et al.
2002-04-18
Eplerenone crystalline form exhibiting enhanced dissolution rate
App 20020038021 - Barton, Kathleen P. ;   et al.
2002-03-28
Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesulfonamide
App 20010003752 - Talley, John J. ;   et al.
2001-06-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed